You searched for: Guide to NHS (408 results)

Summary table of interventions

NHS England has identified the following interventions where comparative data on costs and benefits is available which should deliver a significant reduction in PYLL. We would recommend that commissioners give consideration to these interventions as part of work to set a local level of ambition on mortality. These are set out in two groups. For […]

View

11. Resources to support CCGs

Informed by the joint strategic needs assessment, both NHS England area teams and local authority public health teams should be able to provide practical assistance to commissioners in terms of understanding local priorities and setting an achievable level of ambition. 11.1   Strategic Clinical Networks (SCNs) 11.2   Academic Health Science Networks (AHSNs) 11.3   Other sources […]

View

8. Maternal and neonatal paediatric interventions

Every year in the UK over 6,500 babies die just before, during or soon after birth.  While other countries have succeeding in reducing their rates of stillbirth, the UK’s the figure is still largely unchanged from a decade ago. The following section is work in progress. NHS England intends to undertake further work, in partnership […]

View

10. Other interventions

There are a range of interventions that we have identified which are likely to have a significant impact on reducing premature mortality, but which do not sit within a discrete pathway of care.  Further details are set out below. 10.1   Ensure compliance with the ‘Sepsis Six’ care bundle 10.2   Implement the British Thoracic Society’s […]

View

9. Reducing premature mortality in people with a learning disability

NHS England is working with a range of partner organisations with a view to seeking to provide a clear steer to commissioners about the evidence base relating to clinical interventions and service developments which are likely to have the greatest impact on reducing mortality for people with a learning disability. Much of the evidence set […]

View

6. Respiratory disease

Chronic Obstructive Pulmonary Disease (COPD) is the fifth biggest killer disease in the UK, killing approximately 25,000 people a year in England. Premature mortality from COPD in the UK was almost twice as high as the European (EU-15) average in 2008 and premature mortality for asthma was over 1.5 times higher.  Although, deaths from asthma […]

View

Bulletin for CCGs: Issue 53, 20 February 2014

Gateway reference number: 01205  Download the bulletin as a PDF   Contents Latest news from Expo14 Register your place at Health and Care Innovation Expo 2014 NHS Commissioning Assembly News: Find out more about the Commissioning Assembly at Expo14 Strategic issues: CCG operational and strategic planning Launch of Commissioning Support Lead Provider Framework process CCGs […]

View

3. Cardiovascular disease (CVD)

CVD affects the lives of millions of people and is one of the largest causes of death and disability in this country. Huge improvements have been made in the prevention and treatment of CVD over the last decade, with a 40% reduction in under 75 mortality rates between 2001 and 2010. Over the same period, […]

View

Signposting to key resources

The resources listed below can support the patient experience elements of strategic planning being undertaken by local commissioners, supported by Area Teams, and also subsequent implementation. Commissioning for improved patient experience: summary of the key themes and discussion from an event on how to commission for improved patient experience. NHS Institute for Innovation and Improvement: […]

View

GP and Practice Team bulletin: January 2014

Publications gateway number: 01083 Foreword Mike Bewick,  Deputy National Medical Director This month we’re leading the Challenge Fund which will support practices in developing innovative ways to extend patient access to primary care. It recognises GP practices’ central role; working with other professionals to develop a more sustainable, patient-centred healthcare service. Before the 2004 contract, […]

View